| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 03/28/2006 | US7018826 Particles for gene therapy |
| 03/23/2006 | WO2006031795A2 Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease |
| 03/23/2006 | WO2006029632A2 Chimeric phage-derived particles, methods for their production and use |
| 03/23/2006 | WO2005097981A3 Novel herpes simplex viruses |
| 03/23/2006 | WO2005058006A3 Methods and compositions comprising bacteriophage nanoparticles |
| 03/23/2006 | WO2005049794A3 Methods of characterizing infectious bursal disease virus |
| 03/23/2006 | WO2004108939A3 BAV packaging regions and E1 transcriptional control regions |
| 03/23/2006 | US20060063729 Ocular gene therapy |
| 03/23/2006 | US20060063261 Production of vaccines |
| 03/23/2006 | US20060063259 Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination |
| 03/23/2006 | US20060063250 Use of modified novirhabdoviruses to obtain vaccines |
| 03/23/2006 | US20060062806 Flavivirus variants having phenotypic variation and immunogenic compositions thereof |
| 03/23/2006 | US20060062805 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
| 03/23/2006 | US20060062803 a nucleic acid fhaving a first nucleotide sequence encoding nonstructural proteins from attenuated dengue-2 virus vaccine strain PDK-53, and a second nucleotide sequence encoding a structural protein from a second flavivirus; amino acid mutations in the nontstructural proteins; vaccines |
| 03/23/2006 | US20060062801 Immunogens; electrical injection; electroporation |
| 03/23/2006 | US20060062800 Immunogens; envelope proteins; kits |
| 03/23/2006 | CA2579141A1 Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease |
| 03/22/2006 | EP1637608A2 Recombinant adenoviral vector and methods of use |
| 03/22/2006 | EP1637593A1 Process for the inactivation of enveloped viruses |
| 03/22/2006 | EP1636371A1 Negative strand rna virus replicon |
| 03/22/2006 | EP1636370A2 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 03/22/2006 | EP1636352A1 Improvements in virus production |
| 03/22/2006 | EP1635772A2 Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production |
| 03/22/2006 | EP1322287B1 Microparticles for delivery of the heterologous nucleic acids |
| 03/22/2006 | EP0864645B9 Negative-strand rna virus vector having autonomously replicating activity |
| 03/22/2006 | EP0839184B1 Synthetic hpv11 virus-like particles |
| 03/22/2006 | CN1246333C Receptor in the EDb Fibronection domain |
| 03/21/2006 | US7015026 Isolating infectious and non-infectious adenoviral or adenoassociated vector particles using chromatographic matrix; gene transfer tools and genetic engineering |
| 03/21/2006 | US7015025 Process for producing viral RNA polymerase |
| 03/21/2006 | US7015024 Compositions containing recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences |
| 03/21/2006 | US7015017 Process and agent for instabilizing viral quasi-species-distributions avoiding resistance phenomena |
| 03/21/2006 | US7014847 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 03/21/2006 | CA2182272C Modified papilloma virus l2 protein and vlps formed therefrom |
| 03/16/2006 | WO2005090584A3 Influenza vaccine based on fowl plague viruses |
| 03/16/2006 | WO2004000220A3 Methods for purifying viral particles for gene therapy |
| 03/16/2006 | US20060057574 Tissue specific expression |
| 03/16/2006 | US20060057159 Immunize cats, veterinary medicine |
| 03/16/2006 | US20060057158 Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines |
| 03/16/2006 | US20060057116 Recombinant influenza viruses for vaccines and gene therapy |
| 03/16/2006 | US20060057115 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
| 03/16/2006 | US20060057113 Novel adenoviruses, nucleic acids coding therefor, and use thereof |
| 03/15/2006 | EP1634889A2 Free solution ligand interaction molecular separation method |
| 03/15/2006 | EP1633877A1 Flavivirus replicon packaging system |
| 03/15/2006 | EP1633860A2 IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA |
| 03/15/2006 | EP1633321A2 Method for purifying virus |
| 03/15/2006 | EP1233783B9 Hbv/hcv virus-like particle |
| 03/15/2006 | EP0870049B1 Complementary adenoviral vector systems and cell lines |
| 03/15/2006 | EP0797436B1 Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods |
| 03/15/2006 | CN1746298A Artificial recombinant H7 subinfluenza virus, preparation and use thereof |
| 03/14/2006 | US7011968 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 03/09/2006 | WO2006024543A1 Vaccine against severe accute respiratory syndrome causing coronavirus (sars-cov) |
| 03/09/2006 | WO2006004878A9 Attenuated herpes simplex virus type-2, vectors thereof and immunogenic compositions thereof |
| 03/09/2006 | US20060052317 Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 03/09/2006 | US20060051743 Screening nucleic acid comprising sequence that encodes reverse transciptase domain of DNA polymerase for adefovir-resistant mutations; use in vaccine development |
| 03/09/2006 | US20060051742 Novel assay for the separation and quantification of hemagglutinin antigens |
| 03/09/2006 | US20060051370 Microorganisms for therapy |
| 03/09/2006 | US20060051369 ADAR1 antiviral pathway |
| 03/08/2006 | EP1632564A1 Vaccine against severe accute respiratory syndrome causing coronavirus (SARS-CoV) |
| 03/08/2006 | EP1632247A1 Nucleic acid sequences encoding FMDV proteins capable of associating into a virus-like particle |
| 03/08/2006 | EP1631675A1 Methods and kits for mass production of dsrna |
| 03/08/2006 | EP1631673A2 Recombinant influenza vectors with a polii promoter and ribozymes |
| 03/08/2006 | EP1218019B1 Oncolytic vesicular stomatitis virus |
| 03/08/2006 | EP1078095B1 Viral production process |
| 03/08/2006 | CN1745094A Peptides, antibodies thereto, and their use in the treatment of central nervous system damage |
| 03/08/2006 | CN1744915A Escape mutants of newcastle disease virus as marker vaccines |
| 03/08/2006 | CN1244692C Aujeszkys TK*/gE*/gI* gene dificiency mark live vaccine and preparation method thereof |
| 03/07/2006 | US7009044 hepatitis c virus (HCV); bovine viral diarrhea virus (BVDV); for production of virions for use in antibody neutralization assays; vaccines |
| 03/07/2006 | US7008784 prepared from recombinant expression vector comprising heterologous promoter connected to DNA molecule comprising modified HIV genome devoid of long terminal repeat regulatory regions but containing gag ang pol genes in genomic arrangement |
| 03/07/2006 | US7008622 Methods and compositions for impairing multiplication of HIV-1 |
| 03/07/2006 | US7008621 Regulation of apoptosis in aquatic organisms by aquabirnavirus |
| 03/02/2006 | WO2006022422A1 Modified human hepatitis c virus genomic rna having autonomous replicative competence |
| 03/02/2006 | WO2006022215A1 RECOMBINANT VACCINICA VIRUS DIs STRAIN HOLDING DNA ENCODING SARS-CORONAVIRUS PROTEIN AND UTILIZATION THEREOF |
| 03/02/2006 | WO2005032487A3 Angiotensin-converting enzyme-2 as a receptor for the sars coronavirus |
| 03/02/2006 | WO2005012527A9 Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof |
| 03/02/2006 | WO2004112707A3 Method for purifying virus |
| 03/02/2006 | US20060046295 Helper virus-free AAV production |
| 03/02/2006 | US20060046291 Expressing molecules comprising a coiled-coil sequence fused to G-protein coupled receptor; encapsulation; endothelin, human epidermal growth factor, gag gene |
| 03/02/2006 | CA2578021A1 Modified human hepatitis c virus genomic rna that can be autonomously replicated |
| 03/01/2006 | EP1320583B1 Enhanced replication of hcv rna |
| 03/01/2006 | EP1290205B1 Duplexed parvovirus vectors |
| 03/01/2006 | EP1141250B1 Intein-mediated cyclization of peptides |
| 03/01/2006 | EP1092035B1 Targeted integration into chromosomes using retroviral vectors |
| 03/01/2006 | EP1042358B1 Free solution ligand interaction molecular separation method |
| 03/01/2006 | EP1038001B1 Constitutive expression of non-infectious hiv-like particles |
| 03/01/2006 | CN1742083A Immunizing fish against viral infection |
| 03/01/2006 | CN1741817A A hepatitis c virus codon optimized non-structural NS3/4A fusion gene |
| 02/28/2006 | US7005277 Defective adenoviruses and corresponding complementation lines |
| 02/28/2006 | US7005275 Inducible alphaviral gene expression system |
| 02/28/2006 | US7005130 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans |
| 02/28/2006 | CA2180346C Herpesvirus pre-(viral dna replication) enveloped particles |
| 02/23/2006 | WO2005089795A3 Infectious bursal disease virus antigenic isolates and vaccines |
| 02/23/2006 | WO2005080556A3 Virus purification methods |
| 02/23/2006 | WO2005004988A3 Compositions and methods relating to novel compounds and targets thereof |
| 02/23/2006 | US20060040347 Use of triplex structure DNA in transferring nucleotide sequences |
| 02/23/2006 | US20060040259 Administering an inhibitor of prenyl cysteine methyltransferase; inhibiting the prenylation or a post-prenylation reaction of a protein contained in the virus infecting a subject |
| 02/23/2006 | US20060039928 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/23/2006 | US20060039926 show reduced growth and pathogenicity in vivo; comprises a viral genome encoding a p59 protein having at mutation at a specific tyrosine residue; avian infectious bronchitis virus, bovine coronavirus, canine coronavirus, feline infectious peritonitis virus, human coronavirus 229E, human coronavirus OC43 |
| 02/23/2006 | US20060039894 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response |
| 02/23/2006 | CA2575163A1 Adenoviral vector compositions |
| 02/22/2006 | EP1627919A1 An infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |